Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Elaine Dennison, Cyrus Cooper(Southampton General Hospital), Roland Chapurlat(Université Claude Bernard Lyon 1), Stephen H. Gehlbach(University of Massachusetts Chan Medical School), Maurizio Rossini(University of Verona), Melissa Orlandin Premaor(University of Oxford), Kenneth G. Saag(University of Alabama at Birmingham), Johannes Pfeilschifter(Alfried Krupp Hospital), Christian Roux(Hôpital Cochin), Adolfo Díez‐Pérez(Universitat Autònoma de Barcelona), Steven Boonen(KU Leuven), R. Lindsay(University of Manchester), Jonathan D. Adachi(St. Joseph's Hospital), Julie Flahive(University of Massachusetts Chan Medical School), Andrea Z. LaCroix(Fred Hutch Cancer Center), Ethel S. Siris(Columbia University Irving Medical Center), J. C. Netelenbos(Amsterdam UMC Location Vrije Universiteit Amsterdam), Nelson B. Watts(Mercy Health), Frederick A. Anderson(University of Massachusetts Chan Medical School), Susan L. Greenspan(University of Pittsburgh), Frederick H. Hooven(University of Massachusetts Chan Medical School), Juliet Compston(University of Cambridge), Philip N. Sambrook(The University of Sydney), Stuart Silverman(Cedars-Sinai Medical Center)
Cited by 148
Related Papers
Clinician’s Guide to Prevention and Treatment of Osteoporosis
|Osteoporosis International|2014|4.1k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.4k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.6k